Literature DB >> 30747963

Antibiotics for Ceftriaxone Resistant Gram-Negative Bacterial Bloodstream Infections-Reply.

Patrick N A Harris1, Paul Tambyah2, David L Paterson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30747963     DOI： 10.1001/jama.2018.19353

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

1.  Piperacillin-tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen).

Authors:  Roni Bitterman; Fidi Koppel; Cristina Mussini; Yuval Geffen; Michal Chowers; Galia Rahav; Lior Nesher; Ronen Ben-Ami; Adi Turjeman; Maayan Huberman Samuel; Matthew P Cheng; Todd C Lee; Leonard Leibovici; Dafna Yahav; Mical Paul
Journal:  BMJ Open       Date:  2021-02-08       Impact factor: 2.692

2.  Cephalosporins-induced intestinal dysbiosis exacerbated pulmonary endothelial barrier disruption in streptococcus pneumoniae-infected mice.

Authors:  Jia-Feng Wang; Chang-Yi Shi; Hua-Zhong Ying
Journal:  Front Cell Infect Microbiol       Date:  2022-08-24       Impact factor: 6.073
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.